Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Neurocrine Biosci

Article Abstract:

The price appreciation potential of the shares of Neurocrine Biosciences Inc. for the years 2010-2012 is discussed. The San Diego, California-based company offers pharmaceutical products for treatment of disorders of the endocrine and nervous systems such as insomnia and mood disorders.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Pharmaceutical industry, Stock prices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neurocrine Biosciences

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Neurocrine Biosciences from 1996 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Drugs, Securities issued, listed, Biotechnology industry, Company sales and earnings, Company earnings/profit, Company securities

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Biotechnology industries, Securities, Neurocrine Biosciences Inc.
Similar abstracts:
  • Abstracts: Myriad Genetics. Neurocrine Biosciences Inc
  • Abstracts: Techne Corp. Medarex Inc
  • Abstracts: MedImmune Inc. Cyberonics, Inc
  • Abstracts: Nektar Therap'tics. Nektar Therapeutics
  • Abstracts: Studying the accuracy of managers' perceptions: a research odyssey. Asking a straightforward question: managers' perceptions and managers' emotions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.